These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30935661)

  • 1. Activated Protein C for Ischemic Central Retinal Vein Occlusion: One-Year Results.
    Hara C; Kamei M; Sakaguchi H; Matsumura N; Sakimoto S; Suzuki M; Nishida K; Fukushima Y; Nishida K
    Ophthalmol Retina; 2019 Jan; 3(1):93-94. PubMed ID: 30935661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
    Iturralde D; Spaide RF; Meyerle CB; Klancnik JM; Yannuzzi LA; Fisher YL; Sorenson J; Slakter JS; Freund KB; Cooney M; Fine HF
    Retina; 2006 Mar; 26(3):279-84. PubMed ID: 16508427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
    Sakuma T; Mizota A; Inoue J; Tanaka M
    Am J Ophthalmol; 2010 Dec; 150(6):876-82. PubMed ID: 20801424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion.
    Udaondo P; Díaz-Llopis M; García-Delpech S; Salom D; Romero FJ
    Arch Ophthalmol; 2011 Mar; 129(3):283-7. PubMed ID: 21402982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
    Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
    Retina; 2005; 25(7):846-50. PubMed ID: 16205562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.
    Pichi F; Elbarky AM; Elhamaky TR
    Int Ophthalmol; 2019 Jan; 39(1):145-153. PubMed ID: 29274022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
    Udaondo P; Garcia-Delpech S; Salom D; Garcia-Pous M; Díaz-Llopis M
    Am J Ophthalmol; 2011 Aug; 152(2):326-7; author reply 327-8. PubMed ID: 21784203
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective analyses of optical coherence tomography in recurrent macular edema following intravitreal therapy in patients with retinal vein occlusion.
    Holland SM; Dodwell DG; Krimmel DA; de Fiebre CM
    BMC Ophthalmol; 2015 Sep; 15():117. PubMed ID: 26337708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OUTER RETINAL LAYER CHANGES AFTER DEXAMETHASONE IMPLANT FOR CENTRAL RETINAL VEIN OCCLUSION.
    Battaglia Parodi M; Iacono P; Scaramuzzi M; Bandello F
    Retina; 2017 Oct; 37(10):1888-1895. PubMed ID: 28030428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion.
    Son BK; Kwak HW; Kim ES; Yu SY
    Korean J Ophthalmol; 2017 Jun; 31(3):209-216. PubMed ID: 28471106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION.
    Matsumoto M; Suzuma K; Yamada Y; Tsuiki E; Fujikawa A; Kitaoka T
    Retina; 2018 Feb; 38(2):283-291. PubMed ID: 28151838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data.
    Chatziralli I; Theodossiadis G; Moschos MM; Mitropoulos P; Theodossiadis P
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1093-1100. PubMed ID: 28214955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.